Occurrence of BK Virus and Human Papilloma Virus in colorectal cancer

Adrian Jarzyński 1  ,  
Department of Virology, Medical University, Lublin, Poland
Ann Agric Environ Med 2017;24(3):440–445
Introduction and objective:
Colorectal cancer is one of the most common cancers worldwide. In Poland, it is the second most common cancer, regardless of gender. The aim of study was to analyze the incidence of HPV and BKV in the tissue of colorectal cancer and to determine the relationship between the presence of these viruses and the development of this cancer.

Material and Methods:
The experiments were conducted using 50 colorectal cancer tissues collected from histological sections. The clinical material was embedded in paraffin blocks. Next, DNA extraction was performed. Isolates of colorectal cancer tissue were tested for the presence of HPV DNA. BKV DNA was detected by PCR using specific primers and then differentiated from JCV by digestion with BamHI enzyme.

In clinical specimens taken from patients with colorectal cancer, HPV DNA was detected in 20% of cases. In 10% of cases the presence of HPV type 18 was confirmed, in the other 90% of the samples HPV type 16 was detected, while the presence of BKV was confirmed in 30% of cases. Coinfection with HPV and BKV was shown in 12% of patients. In one case, BK virus coexisted with HPV type 18, in the remaining 5 cases with HPV type 16.

Developing colorectal cancer can show no symptoms, even for many years. This is why it is so important to become familiar with as many etiological factors as possible. The development of many human neoplasms is often initiated by exposure to infectious agents – such as bacterial or viral infections. Similar to the human papillomavirus, the BK virus was detected in clinical specimens. It seems that HPV and BKV infections can contribute to the neoplastic process, which requires detailed studies on a larger group of patients.

Adrian Jarzyński   
Department of Virology, Medical University, Lublin, Poland
1. Kubiak A, Hycler W, Trojanowski M. Epidemiologia i profilaktyka raka jelita grubego w Polsce. Probl Hig Epidemol. 2014, 95(3): 636–642.
2. Páleníček L, Renke M, Dębska-Ślizień A, Dobies A, Wołyniec W, Rutkowski B. Nowotwory jelita grubego rozpoznane u pacjentów po przeszczepieniu nerki – opisy dwóch przypadków. Forum Nefrologiczne 2015; 8(3): 176–180.
3. Binefa G, Rodríguez-Moranta F, Teule A, Medina-Hayas M. Colorectal cancer: From prevention to personalized medicine, World J Gastroenterol. 2014, 220(22): 6786–6808.
4. Siegel R, Ward E, Brawley O, et al. Cancer statistics 2011: The impact of eliminating socioeconomic and racial disparties on premature cancer deaths. CA Cancer J Clin 2011; 61(4): 212–236.
5. Korniluk J, Wcisło G, Nurzyński P, i wsp. Epidemiologia raka jelita grubego. Współcz Onkol. 2006; 10: 136–142.
6. Kobus G, Łagoda K, Tyniewicka I, Sawicka J, Snarska K. Częstość występowania raka i polipów jelita grubego u chorych zakwalifikowanych do diagnostycznej kolonoskopii. Probl Hig Epidemiol. 2012, 93(2): 327–333.
7. Majewski S, Pniewski T, Goyal-Stec M. Rola wirusów brodawczaka w rozwoju zmian łagodnych i złośliwych okolicy narządów płciowych. Zakażenia 2005; 6: 58–62.
8. Jefferies S, Foulkes WD. Genetic mechanisms in squamous cell carcinoma of the head and neck. Oral Oncol. 2001; 37(2): 115–126.
9. Wierzbicka M, Józefiak A, Jackowska J, Szydłowski J, Goździcka-Józefiak A. HPV vaccination in head and neck HPV-related pathologies. Otolaryngol Pol 2014; 68: 157–173.
10. Randhawa P, Shapiro R, Vats A. Quantitation of DNA of Polyomaviruses BK and JC in Human Kidneys. J Infect Dis. 2005; 192(3): 504–509.
11. Jiang M, Abend JR, Johnson SF, Imperiale MJ. The role of polyomaviruses in human disease. Virology. 2009; 384: 266–273.
12. Rynans S, Dzieciątkowski T, Młynarczyk G. Zakażenia ludzkimi poliomawirusami osób poddanych immunosupresji. Post Mikrobiol. 2011; 50(3): 191–199.
13. Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002; 347: 488–496.
14. Antonsson A, Green AC, Mallitt KA, O’Rourke PK, Pawlita M, Waterboer T, Neale RE. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J Gen Virol. 2010; 91: 1849–1853.
15. Matłosz B, Durlik M. Śródmiąższowe zapalenie nerki przeszczepionej wywołane wirusem Polyoma BK. Przegląd Epidemiologiczny 2006; 60(1): 133–140.
16. Abend JR, Jiang M, Imperiale MJ. BK virus and human cancer: innocent until proven guilty. Semin Cancer Biol. 2009; 19(4): 252–260.
17. Narayanan, M, Szymanski J, Slavcheva E, Rao A, Kelly A, Jones K, Jaffers G. BK virus associated renal cell carcinoma: case presentation with optimized PCR and other diagnostic tests. Am J Transplant. 2007; 7(6): 1666–1671.
18. Bouvard V, Baan RA, Grosse Y, Lauby-Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Straif K. WHO International Agency for Research on Cancer Monograph Working Group, Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol. 2012; 13(4): 339–340.
19. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. A Can J for Clinicials. 2011; 61: 69–90.
20. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer. 2009; 125: 171–180.
21. Cooper K, McGee J. Humman papillomavirus, integration and cervical carcinogenesis: a clinic-pathological perspective. Mol Path. 1997; 50: 1–3.
22. Damn AS, Rachid K, Zettler CG. Evidence of assosciation of Human papilomavirus and breast carcinomas. Breast Cancer Res Treat. 2004; 84: 131–137.
23. Shen ZY, Hu SP, Lu LC, et al. Detection of human papillomavirus in esophageal carcinoma. J Med Virol. 2002; 68: 412–416.
24. Frisch M, Glimelius B, Van den Brule AJ. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997; 337: 1350–1358.
25. Kirgan D, Manalo P, Hall M, McGregor B. Association of human papillomavirus and colon neoplasm. Arch Surg. 1990; 125: 852–865.
26. Damin DC, Ziegelmann PK, Damin AP. Human papillomavirus infection and colorectal cancer risk: a meta-analysis. Colerectal Disease. 2013; 15: 420–428.
27. Aghakani A, Hamkar R, Ramezani A, Bidari-Zerehpoosh F, Sabeti S, Ghavami N, Banifazl M, Rashid N, Eslamifar A. Lack of papillomavirus DNA in colon adenocarcinoma and adenoma. J Cancer Res Ther. 2014; 10(3): 531–534.
28. Taherian H, Tafvizi F, Fard ZT, Abdirad A. Lack of association between human papilomavirus infections and colorectal cancer. Prz Gastroenterol. 2014; 9(5): 280–284.
29. Dorries K. Molecular biology and pathogenesis of human polyomavirus infections, Dev Biol Stand. 1998; 94: 71–79.
30. Giuliani L, Ronci C, Bonifacio D, Di Bonito L, Favalli C, Perno CF, Syrjanen K, Ciotti M. Detection of Oncogenic DNA Viruses in Colorectal Cance. Anticancer Res. 2008; 28: 1405–1410.
31. Casini B, Borgeze L, Del Nonno F, Galati G, Izzo L, Caputo M, Donnorso RP, Casteli M, Risuleo G, Visca P. Presence and Incidence of DNA Sequences of Human Polyomaviruses BKV and JCV in Colorectal Tumor Tissues. Anticancer Res. 2005; 25: 1079–1086.
32. Fiorina L, Ricotti M, Vanoli A, Luinetti O, Dallera E, Riboni R, Paolucci S, Brugnatelli S, Pauli M, Pedrazzoli P, Baldanti F, Perfetti V. Systematic analisys of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates. Infect Agent Cancer. 2014; 9(18): 1–4.
33. Dahlgren L, Dahlstrand HM, Lindquist D, Hogmo A, Bjornestal L, Lindholm J, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer. 2004; 112(6): 1015-1019.
34. Klussmann JP, Mooren JJ, Lehnen M, Claessen SM, Stenner M, Huebbers CU, et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res. 2009; 15(5): 1779–1786.
35. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000; 89(3): 300–304.
36. Kaya H, Kotiloğlu E, Inanli S, Ekicioğlu G, Bozkurt SU, Tutkun A, et al. Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas. Pathologica 2001; 93(5): 531–534.
37. Hseih Y-Y, Wang J-P, Lin C-S, Four novel single nucleotide polymorphisms within the promoter region of p53 gene and their associations with uterine leiomyoma, Molecular reproduction and development. 2007; 74: 815–820.
Copy url